Eyenovia prices $4M registered direct offering of common stock and warrants at $0.46/unit

HYPERION DEFI, INC.

8,695,653 shares (or equivalents) and 8,695,653 warrants sold at $0.46 per share and accompanying warrant.
Gross proceeds ~$4M; closing expected September 30, 2024.
Warrants exercisable at $0.50/share, begin 6 months post-issuance, expire March 2030.
Net proceeds for Mydcombi and clobetasol commercialization, CHAPERONE myopia study, working capital, possible debt repayment.
Lead placement agent A.G.P./Alliance Global Partners; co-agent Brookline Capital Markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.